Program Overview

University of Colorado Cardiac Amyloidosis Program

The University of Colorado Cardiac Amyloidosis program began in 2012 and includes a team of skilled clinicians in the fields of Hematology/Bone Marrow Transplant, Pathology, Cardiac Imaging, and Interventional Cardiology. This multi-disciplinary team's goal is to facilitate the rapid diagnosis and comprehensive treatment for patients with all types of cardiac amyloidosis.

Program Overview

The University of Colorado Hospital on the Anschutz Medical Campus in Aurora, Colorado is the only hospital in the greater-Colorado region, one of only a handful in the country, that can provide the full spectrum of care for cardiac amyloid patients. Every diagnostic modality for cardiac amyloidosis, including cardiac MRI, Technetium Pyrophosphate nuclear imaging, genetic testing with counseling, myocardial biopsy, and bone marrow biopsy, are routinely performed at our center.

Treatment Options

In addition to comprehensive diagnosis, patients can receive comprehensive treatment within our Advanced Heart Failure program that can include care coordination with local cardiology practices throughout the region. The program also offers advanced treatment options such as Bone Marrow Transplantation, Cardiac Transplantation, and access to the latest clinical trials of new therapeutic agents.

Clinical Programs

The program is part of a broader range of clinical programs, including:

• Adult Congenital Heart Disease
• Advanced Heart Failure, Transplant, MCS/LVAD & Amyloidosis
  • Heart Transplant Clinical Program
  • MCS / LVAD
  • Amyloidosis
• Cardiac Electrophysiology
• Cardiac Imaging
• General Cardiology
• Interventional Cardiology Program
  • Structural Heart Disease
  • Vascular Medicine and Intervention
• Multidisciplinary Programs
  • Cardio-Obstetrics
  • Cardio-Oncology
  • Lipids & Prevention
  • Hypertrophic Cardiomyopathy
  • Sports Cardiology
  • Genetic Cardiomyopathies

Research Areas

The program is supported by a range of research areas, including:

• Basic Translational Research
  • Various labs focused on cardiovascular diseases
• Clinical Trials
  • Interventional
  • Heart Failure
  • Genetics Research
  • Electrophysiology
• Cardiovascular Outcomes, Health Services, and Population Research
  • Colorado Cardiovascular Outcomes Research Group (CCOR)
  • Various labs focused on outcomes and population research
• 3D Coronary Imaging Lab
  • Structural Heart Projects
  • FDA Collaboration
  • Tablet Apps
  • 3D PCI Planner

Faculty and Staff

The program is led by experienced faculty and staff, including:

• Amrut Ambardekar, MD, Director, Cardiac Amyloidosis Program
• David Raymer, MD, Director, Hypertrophic Cardiomyopathy Center
• A team of skilled clinicians and researchers in various fields related to cardiology and amyloidosis.